Abstracts & Commentary
A new randomized controlled trial finds that berberine may act as a gut microbiome modulator for improving gylcemic control, killing some gut microbes and enhancing others.
Dry mouth can be caused by a variety of conditions, but a plant-dipeptide combo supplement appears to improve saliva production and saliva pH.
Roughly two-thirds of women treated for ovarian cancer did not return to a sense of “normal” 18 months after treatment. This study looks at predictors and interventions for persistent symptoms and low quality of life.
This field study demonstrates for the first time that altering real-world settings can change environmental microbiomes in ways that have measurable, impactful effects on human inflammatory status and immune system function.
A large, prospective study found that low frequency of laughter was significantly associated with all-cause mortality and CVD incidence in an older population.
Supplementing with these 2 plants improved glucose control in prediabetics in the short term but not the long term.
Treating sepsis patients with ubiquinone along with standard care lowered some inflammation markers and in-hospital mortality rate.
Insulin levels improved in PCOS patients supplementing with curcumin, but other metabolic parameters did not improve.
Supplementing with omega-3s in the short term (less than 6 months) may do little for preventing dementia, but the effects of long-term supplementation are still being researched.
Medications for Parkinson Disease may decrease butyrate-producing microbes and increase Bifidobacterium and Lactobacillus species, with ramifications for optimal probiotic supplements and diet.
